PharmaShots | Incisive News in 3 Shots

Subscribe Now

CD40L Cell Therapy

BMS Exercises its Option to Globally License Obsidian's CD40L Cell Therapy

BMS Exercises its Option to Globally License Obsidian's CD40L Cell Therapy

September 16, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us